Literature DB >> 3456457

The epidemiology of sarcomas of the uterus.

B L Harlow, N S Weiss, S Lofton.   

Abstract

Data from nine population-based cancer registries (1973-81) were analyzed to examine the demographic characteristics that are related to the occurrence of sarcomas of the uterus. Leiomyosarcoma and mixed mesodermal sarcoma accounted for 86% of 1,452 uterine sarcomas reported, and both were more common in black women than in white women. The incidence of mixed mesodermal sarcoma was low through middle age, after which it rose sharply. The incidence of uterine leiomyosarcoma, however, was highest in middle-aged women and declined thereafter. The age-incidence pattern of uterine leiomyosarcoma resembles that of carcinomas of the female reproductive tract, unlike the pattern of other uterine sarcomas or sarcomas occurring elsewhere. This suggests that one or more factors that play a role in the etiology of carcinomas of the reproductive tract may be involved in the etiology of this tumor as well.

Entities:  

Mesh:

Year:  1986        PMID: 3456457

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  63 in total

1.  A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.

Authors:  Oliver Zivanovic; Lindsay M Jacks; Alexia Iasonos; Mario M Leitao; Robert A Soslow; Emanuela Veras; Dennis S Chi; Nadeem R Abu-Rustum; Richard R Barakat; Murray F Brennan; Martee L Hensley
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

2.  Fertility-sparing treatment of low-grade endometrial stromal sarcoma.

Authors:  Ying Jin; Yan Li; Cheng-Yan Deng; Qin-Jie Tian; Hao Chen; Ling-Ya Pan
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Epithelioid leiomyosarcoma of uterus.

Authors:  Aparna Setia; Shalini Kanotra; Ritika Aggarwal; Dilip Prabhakarrao Bhavthankar
Journal:  BMJ Case Rep       Date:  2012-04-02

Review 4.  Treatment of recurrent endometrial stromal sarcoma with letrozole: a case report and literature review.

Authors:  Vonetta T Sylvestre; Charles J Dunton
Journal:  Horm Cancer       Date:  2010-01-29       Impact factor: 3.869

5.  Long-term treatment of residual or recurrent low-grade endometrial stromal sarcoma with aromatase inhibitors: A report of two cases and a review of the literature.

Authors:  Hyewon Ryu; Yoon-Seok Choi; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim; Hyo Jin Lee
Journal:  Oncol Lett       Date:  2015-09-03       Impact factor: 2.967

Review 6.  Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.

Authors:  Khadra Galaal; Esther van der Heijden; Keith Godfrey; Raj Naik; Ali Kucukmetin; Andrew Bryant; Nagindra Das; Alberto D Lopes
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.

Authors:  Alexia Iasonos; Emily Z Keung; Oliver Zivanovic; Rosanna Mancari; Michele Peiretti; Marisa Nucci; Suzanne George; Nicoletta Colombo; Silvestro Carinelli; Martee L Hensley; Chandrajit P Raut
Journal:  Cancer       Date:  2013-03-01       Impact factor: 6.860

8.  Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.

Authors:  Bernadette Liegl-Atzwanger; Ellen Heitzer; Karin Flicker; Stephanie Müller; Peter Ulz; Ozlen Saglam; Fattaneh Tavassoli; Mojgan Devouassoux-Shisheboran; Jochen Geigl; Farid Moinfar
Journal:  Mod Pathol       Date:  2016-07-01       Impact factor: 7.842

9.  Adenosarcoma of the uterus: a case report.

Authors:  Sivekar Tinar; Salim Sehirali; M Murat Inal; Yusuf Yildrim; Esin Celik; Seyran Yigit
Journal:  MedGenMed       Date:  2004-01-12

Review 10.  Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Authors:  Flora Zagouri; Athanasios-Meletios Dimopoulos; Stelios Fotiou; Vassilios Kouloulias; Christos A Papadimitriou
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.